|
DBN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.55351295663786E-15 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.10065298489326E-12 |
| Normal-vs-Stage2 |
6.53940013251031E-10 |
| Normal-vs-Stage3 |
1.29949999982948E-07 |
| Normal-vs-Stage4 |
1.000860E-04 |
| Stage1-vs-Stage2 |
1.303190E-03 |
| Stage1-vs-Stage3 |
5.204600E-01 |
| Stage1-vs-Stage4 |
9.904600E-01 |
| Stage2-vs-Stage3 |
1.344520E-03 |
| Stage2-vs-Stage4 |
2.629500E-02 |
| Stage3-vs-Stage4 |
6.716800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.81163980986321E-12 |
| Normal-vs-AfricanAmerican |
1.877900E-03 |
| Normal-vs-Asian |
7.80050000037669E-07 |
| Caucasian-vs-AfricanAmerican |
4.758200E-01 |
| Caucasian-vs-Asian |
7.733600E-02 |
| AfricanAmerican-vs-Asian |
6.543400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.73990052868101E-10 |
| Normal-vs-Female |
1.63535851527286E-12 |
| Male-vs-Female |
9.275600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.90339966010811E-10 |
| Normal-vs-Age(41-60Yrs) |
8.40838509930109E-12 |
| Normal-vs-Age(61-80Yrs) |
2.6344999959349E-08 |
| Normal-vs-Age(81-100Yrs) |
1.923780E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.245600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.064000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.686970E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.259600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.877220E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.196000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.875400E-03 |
| Classical-VS-Follicular |
7.827400E-01 |
| Classical-VS-Other |
4.663800E-01 |
| Classical-VS-Normal |
3.33066907387547E-16 |
| Tall-VS-Follicular |
4.339800E-02 |
| Tall-VS-Other |
6.463800E-01 |
| Tall-VS-Normal |
4.297300E-03 |
| Follicular-VS-Other |
6.035600E-01 |
| Follicular-VS-Normal |
1.30810000054105E-07 |
| Other-VS-Normal |
1.150240E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64224189802553E-12 |
| Normal-vs-N1 |
1.456070E-03 |
| N0-vs-N1 |
1.079370E-01 |
|
|
